Today: 25 March 2026
Browse Category

Stock Market 5 January 2026

Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific shares climbed 2.4% to $606.63 after Evercore ISI raised its price target to $650 and reaffirmed an “outperform” rating. The stock traded between $590 and $608.29 on volume of 1.6 million shares. Peers Danaher, Agilent, and Illumina also advanced. Investors await Thermo Fisher’s fourth-quarter results on Jan. 29 and updates on its planned $9.4 billion Clario acquisition.
Palo Alto Networks stock climbs after report flags $400 mln Koi Security talks, analysts turn less bearish

Palo Alto Networks stock climbs after report flags $400 mln Koi Security talks, analysts turn less bearish

Palo Alto Networks shares rose 1.7% to $182.46 after Israeli media reported the company is in talks to acquire Koi Security for about $400 million. Guggenheim upgraded the stock to neutral, while Piper Sandler raised its price target to $265. Cybersecurity stocks broadly gained, with the Global X Cybersecurity ETF up 1.2%. Investors await confirmation on the Koi deal and Palo Alto’s earnings, expected around Feb. 12.
Jabil stock slides on Hanley Energy buy: what the $725 million AI data center deal means for JBL

Jabil stock slides on Hanley Energy buy: what the $725 million AI data center deal means for JBL

Jabil shares dropped 7.3% to $222.90 after the company said it completed its $725 million cash acquisition of Hanley Energy Group. The deal, closed Jan. 2, adds 850 employees and expands Jabil’s data center power capabilities. Investors focused on integration risks and cash outlay, as Jabil’s stock fell while the broader market rose. The company’s annual meeting is set for January 22.
Accenture stock rebounds nearly 2% as Redburn nudges target; dividend date and March earnings in focus

Accenture stock rebounds nearly 2% as Redburn nudges target; dividend date and March earnings in focus

Accenture shares rose nearly 2% Monday to $265.07 after last week’s slide, following a price target increase by Rothschild & Co Redburn to $210. The company recently reported $20.9 billion in new bookings and declared a $1.63 quarterly dividend, payable Feb. 13. Accenture’s annual meeting is set for Jan. 28 in Dublin. Investors await its Q2 earnings call on March 19.
Western Digital (WDC) stock whipsaws as AI memory crunch drives storage trade

Western Digital (WDC) stock whipsaws as AI memory crunch drives storage trade

Western Digital shares fell 0.9% to $186.00 Monday afternoon after rising as much as 4.3% earlier, as investors shifted positions in storage and memory stocks tied to AI infrastructure. A Reuters report cited a global supply crunch in high-bandwidth memory, with some prices doubling since last year. Sandisk rose 1.5%, while Seagate and Applied Digital gained over 3%. Western Digital’s next earnings report is expected February 4.
Marvell stock (MRVL) rises after Melius upgrade sets $135 target ahead of CES CEO chat

Marvell stock (MRVL) rises after Melius upgrade sets $135 target ahead of CES CEO chat

Marvell Technology shares rose 1.5% to $90.69 Monday after Melius Research upgraded the stock to “buy” with a $135 target. The move followed Marvell’s $3.25 billion deal for Celestial AI and ahead of CEO Matt Murphy’s scheduled CES appearance Tuesday. The stock opened at $93.08 and remains about 29% below its 52-week high. Investors also await the U.S. December jobs report on Friday.
JNJ stock slips as talc lawsuits return to the spotlight ahead of earnings

JNJ stock slips as talc lawsuits return to the spotlight ahead of earnings

Johnson & Johnson shares dropped 2.2% to $202.86 Monday, underperforming a rising market as investors rotated out of healthcare stocks. The move comes ahead of key events including the Jan. 9 U.S. jobs report and J&J’s Jan. 21 earnings call. More than 67,000 talc lawsuits remain unresolved, with a special master set to review expert evidence in New Jersey federal court.
Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet shares dropped 6.7% to $447.36 by early afternoon Monday, defying gains in the S&P 500 and Nasdaq. The decline came ahead of the company’s quarterly update, with investors watching for signs of demand shifts after management set a high revenue target for the December quarter. Jabil, Celestica, and Flex also fell. The ISM manufacturing PMI slipped to 47.9 in December, signaling contraction.
IREN stock jumps 11% as bitcoin rallies — what’s driving Nasdaq: IREN today

IREN stock jumps 11% as bitcoin rallies — what’s driving Nasdaq: IREN today

IREN shares jumped about 11% to $47.36 Monday afternoon as bitcoin rose 3.5% to $94,302, lifting crypto-linked stocks. Investors weighed IREN’s AI data center expansion and a $9.7 billion Microsoft contract against bitcoin volatility. Several U.S.-listed miners and Coinbase also gained. Zacks flagged IREN’s rapid GPU growth but called shares “overvalued.”
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics shares fell 9.9% to $31.93 Monday after Novo Nordisk launched its Wegovy weight-loss pill in the U.S. with starter doses priced at $149 per month for cash-pay patients. Novo’s U.S.-listed shares rose 5.1%, while Eli Lilly dropped 3.9%. Viking’s next updates include Phase 3 trial milestones in Q1 and an earnings release expected Feb. 4.
D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

D-Wave Quantum shares jumped nearly 10% to around $30.91 Monday amid a surge in large call-option trades flagged by Benzinga. The rally comes ahead of D-Wave’s CES Foundry appearance Jan. 7–8, where investors are watching for new customer or partnership announcements. QBTS traded between $27.79 and $31.20, with about 31 million shares changing hands by mid-afternoon. Other U.S.-listed quantum stocks also rose.

Stock Market Today

  • iShares S&P Mid-Cap 400 Growth ETF (IJK) Sees Surge in Volume Driven by Chewy and Hims & Hers Health
    March 25, 2026, 2:04 PM EDT. The iShares S&P Mid-Cap 400 Growth ETF (IJK) recorded unusually high trading volume Wednesday afternoon, with over 1.5 million shares traded versus a three-month average of 236,000 shares. The ETF's price rose approximately 0.8% during the session. Key components with notable activity included Chewy, which surged 13.4% on over 14.6 million shares, and Hims & Hers Health, which declined 1.6% on 10.4 million shares traded. Bentley Systems underperformed, slipping 4.5%. This surge in volume highlights heightened investor interest in mid-cap growth stocks within the ETF.
Go toTop